Skip to main content
Erschienen in: Diagnostic Pathology 1/2008

Open Access 01.12.2008 | Case Report

Sickle cell nephropathy with diffuse proliferative lupus nephritis: a case report

verfasst von: Kamal V Kanodia, Aruna V Vanikar, Kamal R Goplani, Sonia B Gupta, Hargovind L Trivedi

Erschienen in: Diagnostic Pathology | Ausgabe 1/2008

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Sickle cell nephropathy (SCN) is an important cause of mortality in patients with sickle cell disease. SCA with systemic lupus erythematosus (SLE) is known in children and less common in adults, however diffuse proliferative lupus nephritis (DPLN) with SCN has rarely been reported in adults. It requires early diagnosis and aggressive management.

Case presentation

We present here a 35 years old lady with sickle cell disease who presented with edema, dyspnoea on exertion, pyuria and had raised s. creatinine of 7 mg%. Her biopsy revealed SCN with DPLN. She is on maintenance hemodialysis after 2 months of diagnosis.

Conclusion

DPLN with SCN is a rare entity with poor prognosis, which may be overlooked and needs aggressive management.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1746-1596-3-9) contains supplementary material, which is available to authorized users.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

KK and AV have made the diagnosis by taking care of laboratory management, histopathology, and drafting the manuscript. KG, SG and HT are involved in the clinical management of this patient. HT also finalized the manuscript. All the authors read and approved the manuscript.
Abkürzungen
DPLN
Diffuse Proliferative Lupus Nephritis
SCD
Sickle Cell Disease
SCN
Sickle cell nephropathy
SLE
Systemic lupus erythematosus

Introduction

Sickle cell nephropathy (SCN) is an important cause of mortality in patients with sickle cell disease (SCD) [1]. SCN includes hematuria, papillary necrosis, urinary concentrating defect, impaired renal acidification and potassium excretion, supranormal proximal tubular function, proteinuria, and renal failure1. Incidence of renal failure in SCD ranges from 5 to 18% [2]. SCN associated with diffuse proliferative lupus nephritis (DPLN) is a rare entity. We present here a 35 year old lady with sickle cell disease (SCD) and DPLN.

Case presentation

A 35 year old female with SCD, presented with pedal and periorbital edema, distension of abdomen, decreased urine output and dyspnoea on exertion since 1 month. On examination, she was pale, with pulse rate of 100/minute, normal temperature, and blood pressure was 160/100 mm Hg. Her abdomen was distended due to moderate ascites however there was no organomegaly/scars. Cardio-respiratory and neurological examination was unremarkable. Ultrasonography showed right kidney, 10.9 × 6.0 cm, left kidney of 11.4 × 5.8 cm, with increased echogenicity and maintained cortico-medullary differentiation. Moderate ascites was present.
On investigations, urine albumin was 500 mg/24 hours, microscopy showed 30–40 pus cells and 3–5 granular casts/high power field, urine culture was sterile, serum creatinine, 7.0 mg%, serum proteins, 4.5 gm/dL; serum albumin, 1.8 gm%, serum bilirubin was 0.5 mg/dL, serum alanine amino transferase was 16 units/L, random blood sugar was 87 mg/dL, serum uric acid was 7.5 mg/dL, serum sodium was 134 meq/L and serum potassium, 5.5 meq/L and positive sickling test was noted at 24 hours. Her hemoglobin was 7.1 gm/dL; total leucocyte count was 7,700/cmm with differential count showing neutrophils, 76%, lymphocytes, 20% and eosinophils and monocytes, each, 2%. Peripheral smear showed few crenated and sickled cells with mild hypochromia and anisopoikylocytosis.
She was dialyzed and 2 units of packed cells were transfused. Renal biopsy was performed and after paraffin embedding, 3 micrometer sections were taken and stained using Hematoxylin and eosin, Periodic Acid Schiff, Jone's silver methaneamine and Gomori's trichrome stains. Indirect immunofluorescence studies were performed using anti-human IgG, IgM, IgA, C1q, C3, albumin and fibrinogen anti-sera (DAKO, USA). Histopathology revealed one core with 13 glomeruli. All of them were moderately enlarged in size and 11 had exuberant and occasionally circumferential cellular (rarely fibrocellular) crescents occupying 70–90% urinary spaces, occasionally replacing capillary tufts and shrinking or pushing the capillary tufts towards vascular poles (Figure 1). Capillary tufts had fairly open lumina lined by membranes with occasional reduplication, thickening/rupture. There was uniform moderate mesangial prominence. Capillaries and crescents were infiltrated by few sickle shaped, dysmorphic RBCs, platelet/fibrin thrombi. Afferent and efferent arterioles were filled with sickled RBCs. Bowman capsules were segmentally thickened and occasionally ruptured evoking periglomerular leucocytic reaction. Tubules were moderately degenerated and filled with cellular casts and rarely RBCs. Focal atrophy was also evident. Interstitium was moderately prominent for focal fibrosis and overlying focal mononuclear cellular infiltration with admixed neutrophils. Peri-tubular capillaries were dilated and filled with sickled RBCs (Figure 2). At least one medium caliber and two small caliber arteries showed lumina filled with trapped dysmorphic RBCs.
Immunofluorescence studies showed fine granular fluorescence (+2) across 60–80% mesangial regions and adjacent capillaries of all glomeruli on staining with anti-human C3 and (trace/+1) with anti-human IgG, C1q and fibrinogen antisera (Figure 3). Subsequently she was investigated for vasculitis and lupus nephritis. Indirect immunofluorescence and ELISA revealed anti-nuclear antibodies, (normal index: <1, test: 8.5), anti-dsDNA antibodies were >200 IU/mL (normal <25 IU/mL, Orgentec, Germany). Anti-neutrophil cytoplasmic antibodies were absent. Final diagnosis was made as SCN with DPLN, ISN/RPS class IV-G (A).
Hemoglobin variant study using High Performance Liquid Chromatography (d-10, Biorad, USA) was performed 5 days after transfusion which showed HbSA of 6.9% (Figure 4).
She was treated with Methylprednisolone 500 mg, intravenously for 3 days and Cyclophosphamide, 500 mg intravenously immediately and dose was repeated after 21 days. Then she was switched over to oral Prednisolone, 40 mg/day. Hemodialysis was done on alternate days for 21 days. At follow-up of 2 months, she is on maintenance dialysis with urine output of less than 400 ml/day.

Discussion

Patients with SCA are known to develop idiopathic nephrotic syndrome with focal and segmental glomerulosclerosis or with membranoproliferative glomerulonephritis. Systemic lupus erythematosus (SLE) has been reported in adults and more frequently in children with SCD [3, 4]. However lupus nephritis with SCN has been rarely documented in adults. It is postulated that a defect in the alternate pathway of complement activity seen in patients with SCD may predispose to immune complex disorders [5]. There are broad spectrum of systemic complications associated with SCD and/or SLE [6, 7]. Mesangial expansion, basement membrane duplication as well as occurrence of immune complex disorders in SCD may delay the unmasking of lesion due to SLE unless serological work-up is done. This is a rare case of DPLN along with SCN in an adult, who has become dialysis dependent.

Conclusion

SCN with DPLN is a rare clinico-pathologic entity which requires timely diagnosis and aggressive management.

Acknowledgements

We are thankful to Mr. Babubhai Patel, Mr. Jaydatt Chudasma and Ms. Pinki Bhavsar for preparing the histopatholgy and immunofluorescence slides of this patient, and Mr. Vipul Gandhi and Mr. Yazdi Wadia for manuscript preparation.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

KK and AV have made the diagnosis by taking care of laboratory management, histopathology, and drafting the manuscript. KG, SG and HT are involved in the clinical management of this patient. HT also finalized the manuscript. All the authors read and approved the manuscript.
Anhänge

Authors’ original submitted files for images

Literatur
1.
Zurück zum Zitat Stuart MJ, Nagel RL: Sickle cell disease. Lancet. 2004, 364 (9442): 1343-60. 10.1016/S0140-6736(04)17192-4.CrossRefPubMed Stuart MJ, Nagel RL: Sickle cell disease. Lancet. 2004, 364 (9442): 1343-60. 10.1016/S0140-6736(04)17192-4.CrossRefPubMed
2.
Zurück zum Zitat Scheinman JI: Sickle cell nephropathy. Pediatric Nephrology. Edited by: Holliday M, Barratt TM, Avner ED. 1994, Baltimore, Williams & Wilkins, 908-919. Scheinman JI: Sickle cell nephropathy. Pediatric Nephrology. Edited by: Holliday M, Barratt TM, Avner ED. 1994, Baltimore, Williams & Wilkins, 908-919.
3.
Zurück zum Zitat Saxena VR, Mina R, Moallem HJ, Rao SP, Miller ST: Systemic lupus erythematosus in children with sickle cell disease. J Pediatr Hematol Oncol. 2003, 25 (8): 668-71. 10.1097/00043426-200308000-00019.CrossRefPubMed Saxena VR, Mina R, Moallem HJ, Rao SP, Miller ST: Systemic lupus erythematosus in children with sickle cell disease. J Pediatr Hematol Oncol. 2003, 25 (8): 668-71. 10.1097/00043426-200308000-00019.CrossRefPubMed
4.
Zurück zum Zitat Flanagan G, Packham DK, Kincaid-Smith P: Sickle cell disease and the kidney. Am J Kidney Dis. 1993, 21 (3): 325-7.CrossRefPubMed Flanagan G, Packham DK, Kincaid-Smith P: Sickle cell disease and the kidney. Am J Kidney Dis. 1993, 21 (3): 325-7.CrossRefPubMed
5.
Zurück zum Zitat Shariff S, Al-Hemi B, Al Yousif R, Jabreel N, Al Gharreb S, Balaji D: Spectrum of renal disease in sickle cell anemia. Indian J Nephrology. 2006, 16: 157-163. Shariff S, Al-Hemi B, Al Yousif R, Jabreel N, Al Gharreb S, Balaji D: Spectrum of renal disease in sickle cell anemia. Indian J Nephrology. 2006, 16: 157-163.
6.
Zurück zum Zitat Khalidi NA, Ajmani H, Varga J: Coexisting systemic lupus erythematosus and sickle cell disease: a diagnostic and therapeutic challenge. J Clin Rheumatol. 2005, 11 (2): 86-92. 10.1097/01.rhu.0000158549.92844.96.CrossRefPubMed Khalidi NA, Ajmani H, Varga J: Coexisting systemic lupus erythematosus and sickle cell disease: a diagnostic and therapeutic challenge. J Clin Rheumatol. 2005, 11 (2): 86-92. 10.1097/01.rhu.0000158549.92844.96.CrossRefPubMed
7.
Zurück zum Zitat Saborio Pablo, John J, Scheinman : Sickle cell nephropathy. J Am Soc Nephrol. 1999, 10 (1): 187-92.PubMed Saborio Pablo, John J, Scheinman : Sickle cell nephropathy. J Am Soc Nephrol. 1999, 10 (1): 187-92.PubMed
Metadaten
Titel
Sickle cell nephropathy with diffuse proliferative lupus nephritis: a case report
verfasst von
Kamal V Kanodia
Aruna V Vanikar
Kamal R Goplani
Sonia B Gupta
Hargovind L Trivedi
Publikationsdatum
01.12.2008
Verlag
BioMed Central
Erschienen in
Diagnostic Pathology / Ausgabe 1/2008
Elektronische ISSN: 1746-1596
DOI
https://doi.org/10.1186/1746-1596-3-9

Weitere Artikel der Ausgabe 1/2008

Diagnostic Pathology 1/2008 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …